Barclays PLC Zoetis Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Zoetis Inc. stock. As of the latest transaction made, Barclays PLC holds 32,500 shares of ZTS stock, worth $4.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,500
Previous 1,453,932
97.76%
Holding current value
$4.68 Million
Previous $227 Million
97.76%
% of portfolio
0.0%
Previous 0.09%
Shares
32 transactions
Others Institutions Holding ZTS
# of Institutions
2,126Shares Held
431MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.04 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.31 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.84 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.55 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.29 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $67.5B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...